Simplex Trading’s Legend Biotech LEGN Stock Holding History

Simplex Trading’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$84K	Buy	+2,907	New	+$78.4K	﹤0.01%	5766
2026 Q1	–	Sell	-29,432	Closed	-$561K	–	9655
2025 Q4	$640K	Buy	+29,432	New	+$843K	﹤0.01%	3059
2025 Q3	–	Sell	-10,371	Closed	-$383K	–	9578
2025 Q2	$368K	Buy	10,371 +1,847	+22%	+$59.9K	﹤0.01%	3841
2025 Q1	$289K	Sell	8,524 -1,786	-17%	-$64.1K	﹤0.01%	3951
2024 Q4	$335K	Buy	+10,310	New	+$427K	﹤0.01%	3948
2024 Q3	–	Sell	-6,151	Closed	-$328K	–	9070
2024 Q2	$272K	Buy	+6,151	New	+$284K	﹤0.01%	4334
2024 Q1	–	Sell	-704	Closed	-$42.5K	–	9388
2023 Q4	$42K	Buy	+704	New	+$44.6K	﹤0.01%	6255
2022 Q2	–	Sell	-1,681	Closed	-$71K	–	10569
2022 Q1	$61K	Buy	+1,681	New	+$66.4K	﹤0.01%	6854
2021 Q4	–	Sell	-2,003	Closed	-$102K	–	10968
2021 Q3	$83K	Hold	2,003	–	–	﹤0.01%	6884
2021 Q2	$82K	Buy	2,003 +1,984	+10,442%	+$67.4K	﹤0.01%	7013
2021 Q1	$0	Buy	+19	New	+$518	﹤0.01%	9448

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Simplex Trading's LEGN Position: Q2 2026 in Review

Simplex Trading opened a new position in Legend Biotech (LEGN) in Q2 2026: 2,907 shares worth $84K. The stake represents ﹤0.01% of the portfolio and ranks #5766 among its holdings. This is a return to the name: Simplex Trading previously reported a position in LEGN as recently as Q4 2025.

Simplex Trading first reported a position in LEGN in Q1 2021 and has held it in 11 quarters since. The position peaked at $640K in Q4 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Simplex Trading held 2,907 shares of Legend Biotech worth $84K as of Q2 2026.
Legend Biotech was a new Simplex Trading position in Q2 2026.
Legend Biotech made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5766 holding.
Simplex Trading first reported a position in Legend Biotech in Q1 2021 and has held it in 11 quarters since.
Simplex Trading's Legend Biotech position peaked at $640K in Q4 2025.
219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.